Cargando…
Mass spectrometry based metabolomics for in vitro systems pharmacology: pitfalls, challenges, and computational solutions
INTRODUCTION: Mass spectrometry based metabolomics has become a promising complement and alternative to transcriptomics and proteomics in many fields including in vitro systems pharmacology. Despite several merits, metabolomics based on liquid chromatography mass spectrometry (LC–MS) is a developing...
Autores principales: | Herman, Stephanie, Emami Khoonsari, Payam, Aftab, Obaid, Krishnan, Shibu, Strömbom, Emil, Larsson, Rolf, Hammerling, Ulf, Spjuth, Ola, Kultima, Kim, Gustafsson, Mats |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438430/ https://www.ncbi.nlm.nih.gov/pubmed/28596718 http://dx.doi.org/10.1007/s11306-017-1213-z |
Ejemplares similares
-
Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry
por: Carlsson, Henrik, et al.
Publicado: (2020) -
Container-based bioinformatics with Pachyderm
por: Novella, Jon Ander, et al.
Publicado: (2019) -
Disease phenotype prediction in multiple sclerosis
por: Herman, Stephanie, et al.
Publicado: (2023) -
Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington’s disease subjects
por: Herman, Stephanie, et al.
Publicado: (2019) -
Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis
por: Herman, Stephanie, et al.
Publicado: (2018)